Skip to main content

Impact of Reimbursement for Biomarker Testing on Clinical Practice

Drs. Geoffrey Oxnard and Lauren Ritterhouse deliberate on ways reimbursement issues are impacting clinical practice, particularly CMS’s “14-Day Rule.”

Related Items